Article Details
Retrieved on: 2021-05-26 16:01:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biopharma is currently evaluating Anavex2-73, or blarcamesine, in three Rett syndrome trials. It is assessing the drug in adults in the randomized, ...
Article found on: www.streetwisereports.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here